References
- Minoura, N., M. Tsukada, and M. Nagura. 1990. Physicochemical properties of silk fibroin membrane as a biomaterial. Biomaterials 11: 430--434.
- Minoura N., S. I. Aiba, M. Higuchi, Y. Gotoh, M. Tsukada, and Y. Imai. 1995. Attachment and growth of fibroblast cells on silk fibroin. Biochem. Biophys. Res. Commun. 208: 511516.
- Qian J., Y. Liu, H. Liu, T. Yu, and J. Deng. 1997. Immobilization of horseradish peroxidase with a regenerated silk fibroin membrane and its application to a tetrathiafulvalenemediating H202 sensor. Biosens. Bioelectron. 12: 1213-1218.
- Hanawa, T.,A Watanabe, T. Tsuchiya, R Ikoma, M. Hidaka, and M. Sugihara. 1995. New oral dosage form for elderly patients: preparation and characterization of silk fibroin gel. Chem. Pharm. Bull. 42: 282-288.
- Luo, J., K. Chen, Q. Xu, and K. Hirabayashi. 1993. Study on foodization of fibroin and its functionality, pp. 73-87. In The collection of papers for the second international silk conference, China.
- Akai, H. 1999. New physiological functions of silk material. Shokuhin to Kaihatsu 34: 45-47.
- Gotoh, K., H. Izumi, T. Kanamoto, Y. Tamada, and H. Nakashima. 2000. Sulfated fibroin, a novel sulfated peptide derived from silk, inhibits human immunodeficiency virus replication in vitro. Biosci. Biotechnol. Biochem. 64: 16641670.
- Takano, R, K. Hirabayashi, and K. Chen. 1991. Preparation of soluble silk fibroin powder by hydrochloric acid hydrolysis. Sov. Phys. Crystallogr. 60: 358-362.
- Chen, K., Y. Umeda, and K. Hirabayashi. 1996. Enzymatic hydrolysis of silk fibroin. J. Seric. Sci. Jpn. 65: 131-133.
- Kim, M. K.., K. H. Lee, H. J. Lim, S. J. Lee, S. H. Lee, and K. S. Min. 1996. Preparation protocols for the functional polypeptide materials from cocoon. Korean Patent 98712.
- Kim, D. K., Y. H. Kim, K.. B. Kim, and Y. G. Chin. 2001. The changes of molecular weight and structure in the preparation process of silk fibroin powder. J. Kor. Fiber Soc. 38: 105-110.
- Nahm, J. H. and Y. S. Oh. 1995. A Study of pharmacological effect of silk fibroin. RDA J. Agric. Sci. 37: 145-157.
- Meisel, H. 1997. Biochemical properties of bioactive peptides derived from milk proteins: potential nutraceuticals for food and pharmaceutical applications. Livestock Prod. Sci. 50: 125-138.
- Gill, I., R Lopez-Fandino, X. Jorba, and E. N. Vulfson. 1996. Biologically active peptides and enzymatic approaches to their production. Enz. Microb. Techno!. 18: 162-183.
- Urban, J. L., H. M. Shepard.T, L. Rothstein, B. J. Sugarman, and H. Schreiber. 1986. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc. Natl. Acad. Sci. USA 83: 5233-5237.
- Nathan, C. 1992. Nitric Oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
- Nathan, C. 1995. Natural resistance and nitric oxide. Cell 82: 873-876.
- Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immuno!. Today 13: 265-270.
- Schlimme, E. and H. Meisel. 1995. Bioactive peptides derived from milk proteins. Structural, physiologicaland analytical aspects. Die Nahrung 39: 1-20.
- Kayser, H. and H. Meisel. 1996. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett. 383: 18-20. https://doi.org/10.1016/0014-5793(96)00207-4
- Sohn, D. H. 1997. Bioactive peptides enhancing health and their applications. Food Sci. Industry 30: 22-29.
- Yoshikawa, M., K. Kishi, M. Takahashi, A Watanabe, T. Miyamura, M. Yamazaki, and H. Chiba. 1993. Immunostimulating peptide derived from soybean protein. Ann. N. Y. Acad. Sci. 685: 375-376.
- Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141: 2407-2412.
- Carmichael, J., W. G. DeGraff, A F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-942.
- Remillard, J. F., M. C. Gould, P. F. Roslansky, and T. J. Novitsky. 1987. Quantitation of endotoxin in products using the LAL kinetic turbidimetric assay. Prog. Clin. Biol. Res. 231: 197-210.
- Hyun, C. K. and H. K. Shin. 2000. Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides. Process Biochem. 36: 65-71. https://doi.org/10.1016/S0032-9592(00)00176-X
- Stuehr, D. J., S. S. Gross, I. Sakuma, R. Levi, and C. F. Nathan. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endotheliumderived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169: 1011-1120.
- Nishioka, K., A Constantopoulos, P. S. Satoh, and V. A Najjar. 1972. The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin. Biochem. Biophys. Res. Commun. 47: 172-179.